All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Grade 4 Nervous System Disorders - Other, Specify, CTCAE | NCIT_C146011 | [Life-threatening consequences; urgent intervention indicated] |
| Nervous System Disorders - Other, Specify, CTCAE | NCIT_C143702 | |
| High-Dose Rate Brachytherapy | NCIT_C15651 | [Internal radiation treatment that targets a cancerous tissue with accurate, high doses of radiation through the use of inserted temporary implants.] |
| Internal Radiation Therapy | NCIT_C15195 | [A type of radiation therapy in which radioactive material is placed inside the body, into a tumor or body cavity.] |
| Grade 4 Neutrophil Count Decreased, CTCAE | NCIT_C146012 | [<500/mm3; <0.5 x 10e9/L] |
| Neutrophil Count Decreased, CTCAE | NCIT_C143704 | [A finding based on laboratory test results that indicate a decrease in number of neutrophils in a blood specimen.] |
| Image Guided Biopsy | NCIT_C15652 | [The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis, using imaging technology.] |
| Biopsy | NCIT_C15189 | [The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.] |
| Organ | NCIT_C13018 | [A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.] |
| Grade 4 Night Blindness, CTCAE | NCIT_C146013 | [Best corrected visual acuity of 20/200 or worse in the affected eye] |
| Night Blindness, CTCAE | NCIT_C143705 | [A disorder characterized by an inability to see clearly in dim light.] |
| Drug Formulation Process | NCIT_C15653 | [The act or process of developing or preparing a mixture of ingredients to create a desired end drug product, such as a specific flavor, aroma, or polymer; or the desired final drug product itself; also, a listing of the ingredients and composition of the dosage form.] |
| Drug Development | NCIT_C15760 | [Design, identification, synthesis, extraction, purification, modification, or characterization of potential anticancer agents; studies of their metabolism, distribution, excretion, physiological effects, molecular interactions, structural analysis, toxicity, mechanism of action, antitumor effects in vivo (nonhuman species) or in vitro (human or nonhuman), and phase I and phase II clinical trials.] |
| Grade 4 Obstruction Gastric, CTCAE | NCIT_C146014 | [Life-threatening consequences; urgent operative intervention indicated] |
| Obstruction Gastric, CTCAE | NCIT_C143710 | [A disorder characterized by blockage of the normal flow of the contents in the stomach.] |
| Fractionation | NCIT_C15654 | |
| Grade 4 Optic Nerve Disorder, CTCAE | NCIT_C146015 | [Best corrected visual acuity of 20/200 or worse in the affected eye] |
| Optic Nerve Disorder, CTCAE | NCIT_C143714 | [A disorder characterized by involvement of the optic nerve (second cranial nerve).] |
| Thoracic Surgical Procedure | NCIT_C15655 | [Any surgery performed inside the thoracic cavity.] |
| Grade 4 Oral Cavity Fistula, CTCAE | NCIT_C146016 | [Life-threatening consequences; urgent intervention indicated] |